Trial intelligence / Profile preview

Safety of VSL#3 for Adult Asthmatics

NCT00852124Phase 2Terminated

Sponsor
University of Maryland, Baltimore
Start
Feb 2007
Primary completion
Jan 2013
Modality
Multi-strain Products
Countries
1
01

Overview

A Phase 2 trial of VSL#3 in asthma, sponsored by University of Maryland, Baltimore. Started Feb 2007; status: terminated.

02

Drugs

VSL#3
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00852124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00852124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call